Koala Chlamydia Vaccine Approved in Australia

Australia's veterinary medicine regulator has approved the world's first single-dose vaccine to combat chlamydia in Koalas, a disease responsible for up to half of Koala deaths and a major threat to their survival. Developed over a decade by scientists at the University of the Sunshine Coast, led by Peter Timms and Sam Phillips, the vaccine has shown to reduce the likelihood of Koalas developing symptoms and decrease mortality by at least 65%. This breakthrough offers a vital solution to protect the endangered Koala population, which faces threats from habitat loss, bushfires, and urbanization. The vaccine is being produced by Treidlia Biovet, and further funding is sought for a national rollout. This development follows the Australia — New South Wales government's announcement to reserve 176,000 hectares for the Great Koala National Park, further demonstrating efforts to safeguard the species.